Iran Health 2017: Gerresheimer to showcase its primary packaging made from glass

Düsseldorf/Tehran, (PresseBox) - Gerresheimer is exhibiting its products for the first time at Iran Health in Tehran. Primary packaging made from amber and clear glass for liquid and solid pharmaceuticals will be taking center stage. As well as being the country's biggest pharmaceutical and healthcare trade fair, Iran Health is also one of the largest industry shows in the Middle East.

"We’re delighted to be presenting our products for the first time at this year’s Iran Health in Tehran," says Area Sales Manager Mehran Nilchian. Gerresheimer is keen to provide visitors and experts at Iran Health with comprehensive information on its products and services. At this year’s trade fair, the company will be focusing on primary packaging made from amber and clear glass and suitable for drugs in solid or liquid form.

For instance, Gerresheimer manufactures injection and infusion bottles in hydrolytic classes I and II as well as tubular-glass injection vials that can hold between 1 and 50 ml. Its other core products include ampoules, cartridges, and more specialty products.

The Gerresheimer range encompasses all classes of glass used for pharmaceuticals – types II and III sodium silicate glass as well as type I borosilicate glass. This enables the company to supply the perfect glass packaging to suit drugs of any shape or size. Its extensive glass range means that appropriate packaging solutions can be found for even the most sensitive pharmaceuticals.

Gerresheimer employs the latest techniques and monitoring technology from the development stage right through to production and packing for delivery. Some of its plants even have a fully automated system built around packing robots. Gerresheimer uses cutting-edge clean room technology to guarantee optimum cleanliness for its products in terms of particles and germs.

With bases in Europe, Asia, and the Americas, Gerresheimer specializes in manufacturing primary packaging for pharmaceuticals in line with the relevant pharmacopeias. All of its factories are currently certified to standards including ISO 9001 and ISO 15378.

Between May 14 and 17, Gerresheimer’s pharma specialists will be in the "German Pavilion" (B16/b-9) at Iran Health in Tehran, which is being held at the Tehran Permanent Fairground.

Gerresheimer’s primary packaging glass


Gerresheimer AG

Gerresheimer is a leading global partner to the pharma and healthcare industries. With our specialty glass and plastic products, we contribute to health and well-being. We have worldwide operations and about 10,000 employees manufacture our products in local markets, close to our customers. With our plants in Europe, North America, South America and Asia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Diese Pressemitteilungen könnten Sie auch interessieren

Weitere Informationen zum Thema "Medizintechnik":

Künstliche Intelligenz optimiert das Mobilfunknetz

Das Mo­bil­funk­netz, ein kom­ple­xes Kon­strukt aus Mo­bil­funk­stand­or­ten und Net­z­e­le­men­ten, sorgt da­für, dass Men­schen je­der­zeit und übe­rall mit­ein­an­der te­le­fo­nie­ren und ih­re di­gi­ta­len An­wen­dun­gen nut­zen kön­nen. Die In­stand­hal­tung, Über­prü­fung und Opti­mie­rung ei­ner solch viel­schich­ti­gen Struk­tur er­for­dert je­de Men­ge men­sch­li­ches und tech­ni­sches Know-how. Um kom­ple­xe Zu­sam­men­hän­ge im Mo­bil­funk­netz noch bes­ser zu ver­ste­hen, setzt Te­le­fó­ni­ca Deut­sch­land seit ei­ni­ger Zeit Al­go­rith­men und Künst­li­che In­tel­li­genz (KI) ein.


News abonnieren

Mit dem Aboservice der PresseBox, erhalten Sie tagesaktuell und zu einer gewünschten Zeit, relevante Presseinformationen aus Themengebieten, die für Sie interessant sind. Für die Zusendung der gewünschten Pressemeldungen, geben Sie bitte Ihre E-Mail-Adresse ein.

Es ist ein Fehler aufgetreten!

Vielen Dank! Sie erhalten in Kürze eine Bestätigungsemail.

Ich möchte die kostenlose Pressemail abonnieren und habe die Bedingungen hierzu gelesen und akzeptiert.